Related Experiment Videos
[Prevention in cardiovascular pathology]
1Service de Médecine Interne et d'Hypertension Artérielle, Pavillon Turiaf, Place du Docteur Baylac, 31059 Toulouse, France.
Insights
Evaluating cardiovascular risk is key for managing hypertension and hypercholesterolemia. Treatment decisions, especially for primary prevention in high-risk individuals, should align with national guidelines and patient education is vital.
Area of Science:
- Cardiology
- Public Health
- Preventive Medicine
Context:
- Cardiovascular risk assessment is crucial for managing arterial hypertension and hypercholesterolemia.
- Existing risk equations like Anderson's (Framingham) may not be suitable for all populations, necessitating localized risk estimation.
- Recommendations emphasize treatment decisions based on absolute cardiovascular risk, particularly for primary prevention.
Purpose:
- To highlight the importance of evaluating absolute cardiovascular risk in clinical practice for managing hypertension and hypercholesterolemia.
- To discuss the limitations of generic risk assessment tools and the need for population-specific models.
- To underscore the benefits of pharmacological interventions for hypertension and hypercholesterolemia, especially in high-risk individuals.
Summary:
- National and international guidelines advocate for cardiovascular risk assessment to guide treatment decisions for hypertension and hypercholesterolemia.
- While Anderson's equation is proposed, its applicability is limited, stressing the need for country-specific risk evaluations.
- The benefits of treating hypertension (beta-blockers, diuretics, ACE inhibitors, calcium antagonists) and hypercholesterolemia (statins) are well-established, with greater benefits observed at higher cardiovascular risk levels.
- Secondary prevention is effective, but the focus here is primary prevention, particularly for high-risk patients from an economic perspective.
- Informing the general population about cardiovascular risk factors and promoting patient education through healthcare networks are essential.
Impact:
- Emphasizes the need for tailored cardiovascular risk assessment tools for effective disease management.
- Reinforces the established benefits of pharmacological interventions in reducing cardiovascular events.
- Promotes a public health approach focused on patient education and awareness of cardiovascular risk factors.
Abstract:
National and international recommendations on the management of arterial hypertension and hypercholesterolemia suggest a treatment decision based on the evaluation of absolute cardiovascular risk. In order to evaluate the cardiovascular risk level, Anderson's equation (Framingham) has been proposed but does not apply to the French population. In medical practice, cardiovascular risk has to be appreciated according to the estimated cardiovascular risk of the country or area. The limits of a decision based on cardiovascular risk have been emphasized, particularly the balance age/life expectancy in respect of early prevention of atherosclerosis. However, the benefit of treatment of hypertension with beta-blockers, diuretics and recently ACE inhibitors and calcium antagonists or hypercholesterolemia with statins has been clearly stated--the higher the cardiovascular risk the higher the benefit. Secondary prevention in patients with major cardiovascular events is effective and necessary. The discussion concerns only primary prevention and from an economic point of view may concern patients at high cardiovascular risk. The general population have to be informed on cardiovascular risk factors, and patient education must be encouraged and developed via the healthcare network.